INTRODUCTION
Reports of the emergence of resistance development among pathogenic bacterial strains continue to increase. Infectious diseases will become increasingly less treatable with conventional antibiotics and thus new clinical strategies are urgently needed (Theuretzbacher, 2013) . At the same time, there is a declining effort from pharmaceutical companies in pursuing the development of new classes of anti-infective agents, and few new antibacterial agents are being approved in the United States (Boucher et al., 2009; Jabes, 2011) . Thus, to solve this persistent health problem, the research and development of new anti-infective agents constitutes an important task for academic institutions. Antimicrobial host defense peptides (HDPs) have for many years been considered lead compounds for novel antibiotics (Brogden, 2005; Hancock and Sahl, 2006; Mookherjee and Hancock, 2007) . However, after 30 years of efforts, synthetic antimicrobial peptides have had very limited success. General problems encountered are typically toxicity, cost of raw materials, and susceptibility toward enzymatic degradation (Fjell et al., 2012; Hancock and Sahl, 2006) .
In this study, we characterized the in vitro activity of a proteolytically stable simple host defense peptidomimetic (HDM-4) with low toxicity toward mammalian cells. We showed that HDM-4 counteracted Gram-negative pathogens in a multifunctional manner through membrane disruption and DNA binding.
Additionally, HDM-4 promoted immunomodulatory anti-infective functions by inducing chemokines in immune cells and inhibiting lipopolysaccharide (LPS)-induced pro-inflammatory responses.

RESULTS
Spectrum of Activity and Killing Kinetics
We previously reported that HDM-4 exhibits low toxicity against red blood cells and HeLa cells as well as high antibacterial activity against E. coli multidrug-resistant strains including ESBL and NDM-1 producers (Jahnsen et al., 2012) . The activity against additional Gram-negative bacteria was investigated (Table 1) . Several HDPs reported in the literature were included in the screen: polymyxin B (Storm et al., 1977) , a polypeptide isolated from Bacillus polymyxus; IDR-1018 (Wieczorek et al., 2010) , a synthetic short cationic immunomodulating peptide with weak direct antibacterial activity; CRAMP (Gallo et al., 1997) , a natural cathelin-related murine antimicrobial peptide; and bovine bactenecin derivatives Bac2A and W3 (Hilpert et al., 2005; Wieczorek et al., 2010) .
HDM-4 exhibited broad-spectrum activity at levels (minimum inhibitory concentration [MIC] % 10 mM) comparable to many of the known HDPs (Table 1 ). In particular, the growth of E. coli and K. pneumoniae was inhibited at low concentrations. The killing kinetics of E. coli exposed to HDM-4 were compared to those observed for several clinically applied antibiotics, and HDM-4 was investigated at various concentrations (Figure 1) .
At 4-fold the MIC, HDM-4 killed E. coli more rapidly than other antibiotics commonly used in the clinic (Figure 1 ). Antimicrobial HDPs are proposed to exert their direct bacterial killing by a multimodal mechanism of action involving combinations of disruption of membrane barrier function, antagonism of biosynthetic processes that involve cytoplasmic membrane-associated enzymes, internalization, and action on cytosolic targets (Fjell et al., 2012; Hale and Hancock, 2007) . Thus, upon reaching a threshold concentration, peptides accumulated at the lipid bilayer can rapidly cause cell death as previously shown for polymyxin B (HsuChen and Feingold, 1973) . Notably, HDM-4 acted more slowly than polymyxin B (Figure 1 ), and at low concentrations, the killing took place within hours after an initial lag phase. These observations suggest that alternative more ''slow-acting'' mechanisms other than membrane disruption are involved for HDM-4, most likely implicating inhibition of essential metabolic functions including DNA, RNA, or protein synthesis (Hale and Hancock, 2007) .
Mode of Action
To further elucidate the antibacterial mode of action, the effects of HDM-4 on E. coli were investigated using a range of microscopic and spectroscopic methods as well as functional assays (Figure 2) .
Effects on the outer membrane of E. coli were demonstrated with field emission scanning-electron microscopy ( Figure 2B ). At the MIC, the micrographs clearly showed membrane damage including blebs, especially localized at the end of the bacterial rod. The disruptive effects were more pronounced with increased concentration, which corresponded well to the concentration-dependent killing rate observed in Figure 1B . General morphologic changes were observed at all concentrations, but extensive leakage of intracellular material was only detected at higher concentrations (32 mg/ml; 83 MIC), and even at this concentration cells generally maintained their shapes, indicating a lack of lysis, and thereby corroborating the assumption that intracellular targets may be involved at the MIC. Outer membrane permeabilization of E. coli O157:H7 was measured with the 1-N-phenylnapthylamine (NPN) assay (Loh et al., 1984) with polymyxin B as a positive control ( Figure 2C ). At the MIC (4 mg/ml), HDM-4 caused 75% permeabilization relative to excess polymyxin B. Inner membrane depolarization was then measured using the diSC 3 -5 assay (Wu et al., 1999) with the membrane-active peptide melittin as a positive control (Figure 2D ). To eliminate interference from the outer membrane in uptake of diSC 3 -5, an E. coli (DC2) strain with a weakened outer membrane was used in this assay. The MIC toward this strain was 2-fold higher than that against the O157:H7 strain, consistent with the possibility that outer membrane permeabilization in E. coli was not rate-limiting for HDM-4 action. A strong concentration-dependent activity was observed, but the effect was most pronounced at sub-MIC levels. Nevertheless, at the MIC (8 mg/ml) only 42% depolarization relative to that of excess melittin was observed. Interestingly, further addition of HDM-4 resulted in a more moderate increase in depolarization, while complete depolarization required 103 MIC (40 mg/ml). These data were thus consistent with the suggestion that mechanisms other than inner membrane disruption were involved in killing at the MIC.
To investigate a putative intracellular mechanism for HDM-4, a TAMRA-labeled derivative ( Figure 2A ) was synthesized. To examine the potential impact of the altered physicochemical properties of the labeled compound on its activity, the bacterial killing ability of TAMRA-HDM-4 was compared to that of native HDM-4 ( Figure 2E ). Labeling the compound resulted in a 2-fold increase in MIC as compared to the original compound. An examination of the killing kinetics (adjusted for the difference in MIC) showed comparable time-kill curves during treatment with 83 MIC. The distribution of TAMRA-HDM-4 in bacterial cells after 30 min was depicted with confocal imaging (Figure 2F ). At 0.53 MIC (4 mg/ml) TAMRA-HDM-4 localized only in the membrane, and mainly at the ends of the bacterial rods, whereas general distribution into most parts of the cells was observed at the MIC (i.e., 8 mg/ml). At 43 MIC (32 mg/ml), the membranes were extensively perturbed, and TAMRA-HDM-4 was present also in the area surrounding the bacterial cells. To investigate the capability of HDM-4 for binding intracellular components such as DNA, a gel-retardation assay (Haney et al., 2013) was performed ( Figure 2G ). Inhibition of plasmid migration in the agarose gel was detectable at a HDM-4:plasmid weight ratio of 2:1, with complete inhibition observed at ratios greater than 3:1.
Resistance Development against HDM-4 in E. coli An evaluation of the ability of HDM-4 to induce resistance development in E. coli upon long-term exposure was carried out (Figure 3) .
Because HDM-4 appeared to act via multiple non-specific targets, it was expected that resistance upon repetitive sub-MIC treatment would be less likely to occur for HDM-4 as compared to conventional antibiotics having a single specific target. The investigation indeed demonstrated that E. coli, when exposed to sub-lethal concentrations for 20 cycles, exhibited a higher relative susceptibility to HDM-4 than to representatives of the major antibiotic classes including aminoglycosides (gentamicin), carbapenems (imipenem), cephalosporins (cefotaxime), and fluoroquinolones (ciprofloxacin). Only polymyxin B demonstrated a lower tendency for resistance development because the MIC remained constant after 20 cycles. At least an 8-fold increase in the MIC was obtained for the tested conventional antibiotics, whereas only a 2-fold increase was observed for HDM-4. The resistance properties were not caused by adaptive resistance, as the treated bacteria were grown for additional two cycles The MIC of HDM-4 against several clinically important Gram-negative pathogens.
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Broad-Spectrum Antibiofilm Activity
It was recently demonstrated that small synthetic cationic peptides are able to disrupt bacterial biofilm formation (de la Fuente-Nú ñ ez et al., 2012). A screening for inhibition of biofilm formation by different Gram-negative bacteria was performed ( Figure 4A ). The planktonic MICs in biofilm medium were in two cases slightly different as compared to those obtained in the standard MIC assay medium, being 16-64 mg/ml. Interestingly, inhibition of biofilm formation at sub-MIC concentrations was found for all investigated bacteria. In particular, biofilm growth for P. aeruginosa and A. baumannii was diminished significantly even at a concentration 8-fold lower than the MIC. For all strains, the biomass was reduced by > 90% at 16 mg/ml (i.e., at 0.125-0.53 planktonic cell MIC).
More details about the antibiofilm activity were obtained by subjecting P. aeruginosa to flow cell-based biofilm investigations ( Figure 4B ). Bacteria were allowed to adhere to a glass surface for 2 hr. Subsequently, a continuous flow of medium containing 0.1253 MIC of HDM-4 was applied for 6 days. The biofilm was live/dead stained and visualized with confocal microscopy. In the untreated control, a ''lawn-like'' biofilm with well-defined microcolony structures was seen, and electron microscopy imaging showed a smooth biofilm surface comprising many cells with healthy morphology. In contrast, the treated sample exhibited a majority of dead cells as revealed by staining with both the general stain Syto-9 Green and the normally impermeant stain propidium iodide. A ''lawn-like'' biofilm structure was absent, but well-defined microcolonies were readily detected, albeit that the majority of cells were dead, especially at the core of the biofilm colonies. Electron microscopy revealed smooth bacterial cell surfaces and a relatively high abundance of extracellular polymeric matrix.
Immune Response Modulation
There is evidence that certain host defense peptides (e.g., the human cathelicidin LL-37) also participate in the innate immune response to infections by stimulating chemokine release, thereby mobilizing the immune system (Scott et al., 2002) . Synthetic peptides have been designed to mimic and accentuate this activity (Scott et al., 2007) . Human peripheral blood mononuclear cells (PBMCs) were stimulated with HDM-4 to investigate its ability to induce production of the neutrophil chemokine interleukin 8 (IL-8; CXCL8) as well as the monocyte chemotactic proteins MCP-1 and MCP-3 (also termed CCL2 and CCL7, respectively, because they belong to the subfamily of CC chemokines). The strongly immunomodulatory peptide IDR-1018 (Wieczorek et al., 2010) was included as a positive control. The cytotoxic effects of IDR-1018 and HDM-4 were investigated with the lactate dehydrogenase (LDH) assay (Decker and Lohmann-Matthes, 1988) at relevant concentrations prior to chemokine investigations. At 20 mg/ml, HDM-4 and IDR-1018 demonstrated 7.5 ± 6.7% and 2.2 ± 4.7% LDH release, respectively. At 50 mg/ml, the release was 10.3 ± 7.8% and $0%, respectively.
As expected, a strong induction of chemokines was observed for IDR-1018 at both concentrations tested ( Figure 5A ). No significant chemokine induction was detected for HDM-4 at 20 mg/ml, however, when stimulating with 50 mg/ml, significant induction of all chemokines to levels comparable to those seen for low-dose IDR-1018 treatment was observed.
In response to the bacterial outer-membrane component LPS, the monocytes of infected hosts excrete excessive amounts of pro-inflammatory mediators, like the cytokines IL-6 and tumor necrosis factor-a (TNF-a), that can be harmful and lead to a potentially lethal systemic inflammatory response syndrome (Davies and Hagen, 1997) . LL-37 and certain synthetic peptides are known to inhibit the LPS-induced release of pro-inflammatory cytokines through a complex mechanism (Mookherjee et al., 2006; Turner-Brannen et al., 2011) . In addition, it has been shown that short cationic peptides exert an inhibitory effect on the LPSinduced inflammatory response by blocking the interaction between LPS and LPS-binding protein (Scott et al., 2000) . The ability of HDM-4 to inhibit the LPS-mediated pro-inflammatory response was investigated ( Figure 5B ), and its LPS-binding properties were determined ( Figure 5C ). Because IDR-1018 has been previously shown to strongly inhibit the pro-inflammatory response (Wieczorek et al., 2010) , it was included as a positive control in addition to polymyxin B. Treatment with the compounds alone did not induce significant levels of IL-6 or TNF-a (data not shown). Addition of HDM-4 together with LPS inhibited the release of TNF-a and IL-6 from PBMCs. For TNF-a, both HDM-4 and IDR-1018 completely abolished the cytokine signal, whereas for IL-6, low levels of cytokine could still be detected, with HDM-4 being slightly more efficient than IDR-1018. Both compounds exhibited concentration-dependent fluorophore displacement from LPS, with HDM-4 being slightly more active. Polymyxin B gave rise to a stronger displacement than that seen with both test compounds. (A) Time-kill study of E. coli O157:H7 exposed to various antibacterials. Cultures in log phase at 3.5 3 10 6 to 5.5 3 10 6 CFU/ml were challenged with 4 3 MIC; all numbers recorded as 10 2 had %100 CFU/ml.
(B) Time-kill study of E. coli O157:H7 exposed to HDM-4 at various concentrations relative to the MIC of 4 mg/ml. The experiment was performed three times and one representative curve for each concentration is shown. (B) Scanning-electron micrographs of E. coli O157:H7 exposed to HDM-4 at various concentrations relative to the MIC of 4 mg/ml. Cultures in log phase (3.0-4.0 3 10 7 CFU/ml) were treated for 30 min prior to fixation and sample preparation.
(C) Outer membrane damage of E. coli O157:H7 at low HDM-4 concentrations. At time zero, test compounds were added to the sample. Excess polymyxin B (6.4 mg/ml) demonstrated complete permeabilization. At the MIC (4 mg/ml), $75% permeabilization relative to polymyxin B was observed. The experiment was performed three times and one representative curve for each concentration is shown.
(D) Concentration-dependent cytoplasmic membrane depolarization of E. coli (DC2). The results are presented as mean % depolarization ± SD of three independent experiments assessed relative to that of excess melittin (20 mM = 57 mg/ml). The MIC of HDM-4 against E. coli (DC2) was 8 mg/ml and led to a 42% depolarization. Data are represented as mean ± SEM. (E) Time-kill kinetics for E. coli (O157:H7) exposed to native HDM-4 and TAMRA-labeled HDM-4 (MIC = 8 mg/ml). Cultures in log phase at 3.5-5.5 3 10 6 CFU/ml were challenged with 4 3 MIC; all counts % 100 CFU/ml are depicted as 10 2 CFU/ml. The experiment was performed three times and one representative curve for each concentration is shown.
(F) Confocal micrographs of E. coli (O157:H7) after exposure to TAMRA-labeled HDM-4 (false-colored magenta) at various concentrations and counterstaining with the DNA fluorescent stain 4 0 ,6-diamidino-2-phenylindole (DAPI) (false-colored green). Cultures in log phase (3.9 3 10 7 CFU/mL) were treated for 30 min prior to fixation and sample preparation. The scale bars represent 1 mm. An untreated control was examined to confirm that no background fluorescence was present (data not shown).
(G) Inhibition of plasmid pUCP19 DNA migration on a 1% agarose gel at different HDM-4:plasmid weight ratios.
DISCUSSION
Multidrug-resistant bacteria are becoming increasingly prevalent. As recently as a decade ago, most of these organisms posed little health risk, as they could be treated with one or more conventional antibiotics. Today, the situation has changed dramatically, and, in particular, Gram-negative bacteria like E. coli, Pseudomonas, Klebsiella, and Acinetobacter spp. are considered severe threats to public health (Oteo et al., 2010) .
In the present work, we have extensively characterized the antimicrobial activity and mechanism of action of HDM-4, a nontoxic peptidomimetic with potent broad-spectrum antibacterial activity against a range of Gram-negative species. We propose that HDM-4 may combat bacterial infections in a multifunctional manner and thus, bacterial killing takes place as the result of an overall mode of action involving cell membrane perturbation and binding to intracellular components such as bacterial DNA. In addition, the immunomodulatory properties of HDM-4 could lead to enhanced bacterial clearance by the cells of the host immune system, resulting in a multipronged attack against invading pathogens. HDPs have been called ''dirty drugs'' because they often interact with several low-affinity targets rather than blocking a single high-affinity target, ultimately limiting co-evolution of HDPs and bacterial resistance (Peschel and Sahl, 2006) . This is supported by the present results because assessment of resistance development demonstrated that both polymyxin B and HDM-4 remained highly active against E. coli after continuous treatment with subinhibitory concentrations, in contrast to all tested conventional antibiotics. Still, bacterial resistance toward HDPs has been observed previously due to several defense strategies including altered membrane composition, active efflux, and enzymatic degradation. In the latter case, it has been shown that the human cathelicidin LL-37 is inactivated via proteolytic degradation by S. aureus (Sieprawska-Lupa et al., 2004) . The peptidomimetic structure of HDM-4 is not recognized by proteolytic enzymes providing HDM-4 with an advantage as compared to HDPs composed exclusively of a-amino acids, both with respect to resistance and stability in the face of host proteases that abound during infections.
Importantly, evidence suggests that HDPs generally exert their natural anti-infective functions mainly through immune modulation (Bowdish et al., 2005) . Not surprisingly, this is an advantage in the context of resistance development as such an indirect activity relieves selection pressure. It could be argued that a potential anti-infective drug candidate with multiple mechanisms including direct (i.e., bacterial killing) and indirect (i.e., immune modulation) killing has a higher potential for success in the clinic with reduced resistance development when compared to singlemechanism antibiotics. In the present in vitro investigation, it was demonstrated that HDM-4 constitutes one such candidate.
One way for bacteria to adapt to inhospitable environments involves biofilm formation, which is a microbiological process that is associated with $65% of all human infections and is linked to increased pathogenesis and multidrug resistance (Costerton et al., 1999; Donlan, 2001; Parsek and Singh, 2003) . Biofilms are highly abundant in certain infectious diseases, e.g., P. aeruginosa biofilms in the lungs of patients with cystic fibrosis (Rö mling and Balsalobre, 2012; Singh et al., 2000) . As previously described, peptoids and peptide-peptoid hybrids may be efficient agents in the treatment of both Gram-negative and Gram-positive biofilms (Kapoor et al., 2011; Liu et al., 2013) . HDM-4 exhibits broad-spectrum inhibitory activity against biofilm formation of Gram-negative bacteria at sub-MIC levels, thus expanding its potential applications. Notably, HDM-4 exhibited strong anti-biofilm activity at the same concentration (8 mg/ml) toward four separate Gram-negative bacteria, suggesting that the underlying mode of action against biofilms involves different mechanisms than does the killing of planktonic cells, as also concluded for cationic anti-biofilm peptides (de la Fuente-Nú ñ ez et al., 2012).
It is surprising that the structure of HDM-4, comprising only two different residues, confers properties similar to those exhibited by complex peptide sequences found in Nature. This simple template is desirable because it should reduce the cost-of-goods during large-scale synthesis. Indeed a feasible gram-scale synthesis route for peptoids has been demonstrated (Jahnsen et al., 2012) .
SIGNIFICANCE
In an era in which novel antibiotic agents are greatly needed, we have characterized the activity of a host defense peptidomimetic (HDM-4) with an attractive activity profile including beneficial features such as simplicity of sequence and proteolytic stability. We have demonstrated that HDM-4 mobilizes innate immune defenses and suppresses LPSmediated inflammation, thus reducing the risk of lethal sepsis-related inflammation while maintaining potential protective efficacy. In addition, we have shown that the compound directly fights Gram-negative bacteria in a multifunctional manner and that bacterial killing takes place because of the combined effects of membrane perturbation and targeting of intracellular components. Furthermore, we have provided evidence that this complex mode of action is less likely to confer resistance development in E. coli when compared to the major classes of antibiotics currently used in the clinic, and that activity against multiresistant bacterial biofilms is an added asset. The traditional issues 
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Multifunctional Host Defense Peptidomimetic encountered during antibiotic and HDP development included resistance, toxicity, stability, and cost. HDM-4 provides advantageous properties for each of these criteria and consequently, has high potential as a future anti-infective drug candidate.
EXPERIMENTAL PROCEDURES
Synthesis of HDM-4 and Its Tagged Variant HDM-4 was prepared by automated MW-assisted solid-phase peptide synthesis on a CEM Liberty microwave peptide synthesizer as previously described (Jahnsen et al., 2012) . The fluorescent tag was introduced prior to cleavage from the solid phase. Tagging conditions involved the use of 5 equivalents of 5(6)-carboxy-tetramethylrhodamine (Merck), 5 equivalents of diisopropyl carbodiimide (Iris Biotech), and 5 equivalents of 1-hydroxy-7-aza-benzotriazole (TCI) in the solvent DMF (VWR), with treatment at room temperature, overnight.
Bacterial Strains
Several Gram-negative bacteria were included in the evaluation of the antibacterial activity of HDM-4 including E. coli O157:H7, DC2 (Clark, 1984) 
Antimicrobial Activity
MICs were determined using the broth microdilution method as previously described (Jahnsen et al., 2012) , with minor modifications. In brief, fresh overnight colonies were diluted 1:500 in Mueller Hinton (MH) broth II (Difco). An aliquot (100 ml) of bacterial suspension was added to the wells of a polypropylene microtiter tray (Costar) containing 11 ml of a 10-fold concentration of the desired test compound in 2-fold serial dilutions. The trays were incubated at 37 C for 24 hr. The MIC was determined as the lowest concentration showing no visible growth. All measurements were carried out three times independently in triplicate.
Killing Kinetics
The killing kinetics of E. coli O157:H7 by HDM-4 at various concentrations were investigated, and at 43 MIC HDM-4 was compared to imipenem (Merck), cefotaxime (Sigma), ciprofloxacin (Sigma), and polymyxin B (Sigma). Cultures were allowed to grow to exponential phase (optical density 600 [OD 600 ] of $0.5), and were then diluted to 3.5-5.5 3 10 6 CFU/ml in MH broth II, challenged with test compound, and incubated at 37 C. Residual colony counts were determined after 0.5, 1, 2, 3, and 6 hr by plating for single colonies on MH broth II agar. All measurements were carried out in triplicate.
Outer Membrane Depolarization
The effect of HDM-4 on the permeability of the outer membrane in E. coli O157:H7 was evaluated by the NPN-assay ( and Wong, 1984; Loh et al., 1984) measuring the uptake of 1-N-phenylnapthylamine (NPN) into the bacterial cytoplasmic membrane. The experiment was performed three times.
Inner Membrane Depolarization
Depolarization of the inner membrane was investigated by the diSC 3 -5 (Molecular Probes) assay as previously described (Wu et al., 1999) and later modified (Chongsiriwatana and Barron, 2010) . All measurements of the increase in diSC 3 -5 fluorescence as an assessment of membrane depolarization were carried out three times.
Imaging of Membrane Damage
Membrane damage on E. coli O157:H7 exerted by HDM-4 was demonstrated with field emission scanning-electron microscopy. Bacterial cultures were grown to the exponential phase, and were then diluted to 2-5 3 10 7 CFU/ml in MH broth II as determined by plate counting. The bacteria were pelleted and resuspended in 0.1 M sodium cacodylate (Fluka) buffer (pH 7.4) containing the test compound. The bacteria were treated for 30 min at 23 C prior to fixation with 2.5% glutaraldehyde for 1 hr. Subsequently, the cells were loaded onto a 0.2 mm membrane filter (Whatman Nuclopore Track) using a syringe. The cells were washed with cacodylate buffer, and were then contrasted with 1% osmium tetroxide. The cells were washed with water and dehydrated by using ethanol and nitrogen critical point drying. The specimens were mounted onto stubs with Pelco conductive silver glue and coated with 5 nm gold/palladium using a sputter coater. The images were obtained on a Hitachi S4700 SEM operated at 5 kV and 10 mA at 5.0 mm working distance.
Imaging of Treated E. coli by Confocal Laser Scanning Microscopy
Localization of HDM-4 in E. coli (O157:H7) cells was investigated with TAMRAtagged HDM-4 using confocal laser-scanning microscopy. Bacterial cultures were grown in MH broth II to reach exponential phase, and were then diluted to 3.93 3 10 7 CFU/ml as determined by plate counting. The cells were pelleted and resuspended in 5 mM PBS buffer (as tablets from Sigma: 0.01 M phosphate, 2.7 mM KCl, 0.137 M NaCl, and pH 7.4) containing the test compound. The bacteria were treated for 30 min at 37 C in the dark prior to fixation with 2.5% glutaraldehyde (Alfa Aesar) for 1 hr at 23 C in the dark. The cells were washed twice with PBS buffer, pelleted, and resuspended in PBS buffer containing 10 mg/ml DAPI. The cells were rested for 1 hr at 23 C in the dark. A drop of the bacterial suspension was placed on a coverslip, and imaging of the specimen was carried out with a Zeiss LSM 780 inverted confocal laser-scanning microscopy equipped with lasers for DAPI excitation at 405 nm and TAMRA at 543 nm. Image processing was carried out by using Fiji ImageJ 1.47q. Blue DAPI was falsely colored green and red TAMRA was falsely colored magenta.
DNA Binding Assay
Binding of HDM-4 to plasmid DNA was investigated by using an agarose gelretardation assay for evaluation of antimicrobial peptide binding to DNA as previously described (Haney et al., 2013) with modifications. Unmodified pUCP19 plasmid was purified from an overnight culture of E. coli (DH5a/ pUCP19) cells using a Plasmid Purification Kit (QIAGEN Inc.). Water was used to elute the pUCP19 vector, and the concentration of the purified plasmid was determined by using a NanoDrop machine (NanoDrop Products). Plasmid (200 ng) was incubated at 23 C with increasing amounts of HDM-4 in 20 ml of binding buffer (5% glycerol, 10 mM Tris-HCl at pH 8.0, 1 mM EDTA, 1 mM dithioreitol, 20 mM KCl, and 50 mg/ml BSA). After 1 hr of incubation, 2 ml of 103 loading buffer (Invitrogen) was added to the mixture. Half of this sample (i.e., 100 ng of plasmid) was loaded onto a 1% agarose gel in Tris-acetate-EDTA (TAE) buffer containing SYBR Safe DNA gel stain (Invitrogen). The gel was run at 100 V for approximately 45 min and the DNA bands were depicted with UV light using a Chemigenius 2 Bio Imaging System (Syngene). Resistance Development Sublethal treatment of E. coli O157:H7 with HDM-4, imipenem, cefotaxime, ciprofloxacin, and polymyxin B was carried out as follows: initially, bacteria from the same subculture were plated and treated with test compound as for regular MIC determination. The following day, OD 600 was measured. From the well with the lowest concentration where >50% loss of OD 600 could be detected, bacteria were diluted 1:20 and plated anew. This step was repeated until the bacteria were exposed to a total of 20 sublethal treatments. Bacteria without treatment were plated in parallel. After 20 cycles, MIC was determined as described, and data for treated subcultures were compared to the nontreated subculture. The treated subcultures were grown in test tubes for two cycles, and then MIC comparison was repeated. All MIC determinations were carried out in three independent determinations.
Isolation of Peripheral Blood Mononuclear Cells
Blood from healthy adult volunteers was collected (upon informed consent) in sodium heparin anticoagulant collection tubes (BD Biosciences), in accordance with University of British Columbia ethics permission and guidelines. 
Treatment of PBMCs
PBMCs were diluted to 1 3 10 6 cells/ml in RPMI 1640 medium supplemented with 10% FBS and seeded into a 48-well plate (Costar) with 500 ml in each well. The cells were then left in the incubator for 2 hr at 37 C in 5% CO 2 . The cells were then treated with HDM-4 or IDR-1018 at both 20 mg/ml and 50 mg/ml. As a negative control, 2% Triton X-100 was used. In experiments aimed at determining the LPS-neutralizing effect of HDM-4, Pseudomonas aeruginosa strain H103 LPS was added to give a final concentration of 10 ng/ml. After 24 hr of exposure at 37 C in 5% CO 2 , the content of each well was transferred to an Eppendorf tube, and then the cells were pelleted (Thermo Electron Legend Micro 21) at 2,000 rpm for 10 min. The supernatants were aliquoted and stored at À20 C before cytokine or LDH determinations. All treatments were carried out twice.
LDH Assay
Peptide toxicity against PBMCs was assessed by determining the release of LDH into the supernatant upon treatment, as previously described (Decker and Lohmann-Matthes, 1988) . The assay was carried out five times in duplicate.
ELISA
The levels of various chemokines comprising IL-8, MCP-1, and MCP-3 as well as the pro-inflammatory cytokines IL-6 and TNF-a were detected by using a sandwich ELISA method and eBiosciences kits (Invitrogen, R&D Systems). All ELISAs were carried out in duplicate on at least five biological replicates.
LPS Binding
LPS binding was investigated by Oregon Green-tagged polymyxin fluorophore displacement as previously described (Moore et al., 1986 ) using 4 mg Pseudomonas aeruginosa PAO1 strain H103 LPS. Polymyxin B was used as a positive control while buffer was used as a negative control. All titrations were carried out three times.
Inhibition of Biofilm Formation
Screening for antibiofilm activity was performed in a microtiter plate assay as previously described (Pitts et al., 2003) with minor modifications (de la Fuente-Nú ñ ez et al., 2012). In brief, fresh overnight cultures were diluted in the following manner: E. coli 1:100 in Lennox broth (LB; Fisher Scientific): P. aeruginosa 1:100 in LB, S. typhimurium 1:10 in BM2 glucose medium-62 mM potassium phosphate buffer (pH 7), 7 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 10 mM FeSO 4 , 0.4% (wt/vol) glucose, and 0.5% casamino acids (BDH, Fisher and Sigma)-and A. baumannii 1:10 in LB (Difco). An aliquot (100 ml) of this bacterial suspension was added to the wells of a polypropylene microtiter plate (Costar) containing 11 ml of ten times the desired final concentration of test compound in 2-fold serial dilutions. After incubation at 37 C for 24 hr, adherent biofilm was determined by the crystal violet staining method. The experiment was carried out in triplicate.
Flow Cell Experiments and Biofilm Imaging by Confocal and CryoScanning-Electron Microscopy The flow cell cultivation was carried out as previously described (de la Fuente-Nú ñ ez et al., 2012) with modifications. In brief, fresh overnight cultures of P. aeruginosa PA14 were diluted to 1.5-7.5 3 10 8 CFU/ml in LB as determined by plate counts. Then 400 ml of bacterial suspension was injected into each channel of a three-channel flow cell (IBI scientific), and subsequently the cells were allowed to adhere for 2 hr. A continuous flow of BM2 medium with or without 8 mg/ml HDM-4 at 3.6 ml/hr was applied to the channels, and the biofilm was grown for 144 hr with a setup consisting of Pharmacia LBK pumps and sterilized silicon tubing (VWR). After cultivation, the biofilm was stained with 1 mM Syto-9 (Invitrogen) and 5 mM propidium iodide (Invitrogen) in 0.9% NaCl. Imaging was carried out on an Olympus FV-1000 inverted confocal laser-scanning microscope equipped with lasers for green Syto-9 excitation at 488 nm and red propidium iodide excitation at 568 nm. Three-dimensional reconstruction was carried out in Imaris Bitplane software. After undergoing confocal microscopy, the specimen was fixed with 2.5% glutaraldehyde and depicted with CryoSEM. Small pieces of each flow cell coverslip were excised with a diamond cutter, mounted onto a stub, and plunge-frozen in liquid nitrogen. The stub was transferred to continuous vacuum conditions in a CryoSEM sample preparation container (Emitech K1250). The temperature was increased to À95 C and decreased to À138 C through a 20 min time span to sublimate any condensed water. The sample was coated with 5 nm platinum and transferred to a Hitachi S4700 SEM operated at 5 kV and 10 mA at 12.5-15.0 mm working distance with a 30% specimen tilt.
Statistical Analysis
Statistical analyses were carried out using Graphpad Prism 5 software. All standard curves had R squared values of >0.95 and at least five data points. Data sets were compared with Student's t test for paired data sets and ANOVA for multiple data sets. All data described as significant had at least a 95% confidence interval: *p % 0.5. ****p % 0.0001.
